جست‌وجوی استاد و پژوهشگر

Nathalia Peixotoمشاهده پروفایل

دانشیار

• Neural Engineering
• Brain-Computer Interfaces
• Biomedical Sensors and Actuators
• +۴ مورد دیگر

Nathalia Peixoto is an Associate Professor in the Department of Electrical and Computer Engineering and Affiliate Faculty in Bioengineering at George Mason University. Her work bridges neural engineering, biomedical applications, and assistive technology development with international collaborations across Israel, Ireland, Peru, and Korea. Educational background: PhD in Electrical Engineering, Universidade de Sao Paulo MS, University of Campinas Research Interests: Dr. Peixoto specializes in neural engineering with focus on brain-computer interfaces using wearable devices. Her lab develops: Neural prosthetics and implantable systems Bioimpedance-based medical sensors Low-cost electrophysiological recording platforms Community-centered engineering design solutions Publication Trends: Her 2022-2025 publications demonstrate strong interdisciplinary convergence between neuroscience, biomedical engineering, and AI. Key trends include machine learning for seizure detection in zebrafish models, electrochemical optimization of neural interfaces, and community-engaged design projects addressing societal challenges through transdisciplinary graduate training. Grants and Projects: Principal investigator for multiple NSF-funded initiatives: NRT-HDR: Transdisciplinary Graduate Training (2019-2024) Smart and Connected Communities: Networked Devices (2017-2019) Bioimpedance for retinal implants (2015-2017) C2MW: Classroom to Makers Week (2015-2016) Additional funding from VA STEM CoNNECT and Longwood University. Laboratory: The Neural Engineering Lab integrates chemistry, physics, and engineering disciplines through team-based projects involving high school to graduate students. Current work includes sustainable food-waste solutions, tremor-capturing robots for low-resource areas, and neural implants with international academic partnerships.

Katrina Choeمشاهده پروفایل

استادیار

• Social Neuroscience
• Autism Spectrum Disorders
• Oxytocin Signaling
• +۴ مورد دیگر

Katrina Choe serves as Assistant Professor in the Department of Psychology, Neuroscience & Behaviour at McMaster University and holds a Tier 2 Canada Research Chair in Neurobiology of Social Behaviour. Her research program investigates the multi-level neurobiological mechanisms underlying psychiatric disorders, with primary focus on autism spectrum disorders (ASD) and oxytocin signaling pathways. Her academic training includes: PhD in Neuroscience from McGill University (2013) Honours BSc in Zoology from University of Toronto (2002-2006) Postdoctoral Fellowship at UCLA (2013-2020) Dr. Choe's research employs an integrative approach spanning molecular, cellular, circuit, and network levels to examine how ASD-associated gene mutations disrupt social behavior. Current work centers on oxytocin signaling mechanisms in ASD, convergent neurobiological pathways across psychiatric disorders, and the role of glial cells in neural circuit function. Her lab utilizes advanced techniques including optogenetic fMRI, single-cell RNA sequencing, and multi-level behavioral assays in genetic mouse models. Analysis of her 15 most recent publications reveals a clear research trajectory: early work (2015-2020) established foundational knowledge in vasopressin neuron regulation and salt homeostasis, while recent publications (2022-2025) demonstrate a focused shift toward ASD mechanisms, oxytocin signaling, and social circuit dysfunction using the Cntnap2 knockout model. This evolution reflects her transition from postdoctoral training to independent research leadership. Her scientific recognition includes: Tier 2 Canada Research Chair in Neurobiology of Social Behaviour (2022) NIMH K99/R00 Award CIHR Postdoctoral Fellowship Dr. Choe actively mentors six graduate students across PhD and MSc programs while leading a dynamic research team comprising postdoctoral fellows, laboratory technicians, and undergraduate researchers. Her program receives substantial support from major grants including a 5-year CIHR Project Grant and NSERC Discovery Grant focused on 'The role of CASPR2 in central oxytocin system development.' The Choe Lab maintains active collaborations with leading neuroscience groups including the Bourque, Prager-Khoutorsky, and Cunningham labs, as evidenced by participation in the 4th 1000 Islands/Gananoque Meeting on Hypothalamic Mechanisms. Her laboratory, established in 2020, operates as a multidisciplinary hub utilizing molecular biology (qPCR, RNA-seq), advanced imaging (lightsheet, confocal), electrophysiology (in vitro and in vivo), and behavioral neuroscience approaches to investigate social behavior mechanisms. Current projects examine microglia-astrocyte-neuron interactions in social circuit function and the therapeutic potential of oxytocin for ASD-related social deficits.

• Epilepsy research
• Zebrafish disease modeling
• Drug discovery
• +۳ مورد دیگر

Daniëlle Copmans is an Assistant Professor at the Faculty of Pharmaceutical Sciences , KU Leuven, where she leads the Molecular Biodiscovery unit and the Subdivision Pharmaceutical Biology and Phytopharmacology . Her research focuses on epilepsy and neurodevelopmental disorders , utilizing zebrafish models for drug discovery and precision medicine . She contributes to network pharmacology approaches and iPSC-based disease modeling for rare conditions like Dravet syndrome.

Juan Songمشاهده پروفایل

استاد

• Adult Neurogenesis
• Neuroscience
• Neurodegenerative Diseases
• +۵ مورد دیگر

Dr. Juan Song is a **Professor** and **Jeffrey Houpt Distinguished Investigator** in the Department of Pharmacology at the University of North Carolina (UNC) School of Medicine. Her research focuses on adult neurogenesis mechanisms, neural circuit regulation, and applications to neuropsychiatric disorders and neurodegenerative diseases such as Alzheimer’s. She leads the Song Lab, which employs advanced techniques like optogenetics, electrophysiology, and genetic models. Dr. Song earned her Ph.D. from UC Berkeley and completed postdoctoral training at Johns Hopkins University before establishing her independent lab at UNC in 2013. She was promoted to Full Professor in 2023. **Education**: Ph.D. in Neuroscience, University of California, Berkeley (2007); Postdoctoral Fellowship at Johns Hopkins University (2007–2013). **Research Interests**: Circuit mechanisms regulating adult neurogenesis, hippocampal neurogenesis and memory, Alzheimer’s disease modeling, and translational therapies. Her lab explores how neural circuits influence stem cell activation and newborn neuron integration, with implications for schizophrenia, autism, stroke, and Alzheimer’s. **Publications**: Over 50 peer-reviewed articles, including high-impact work in *Cell Stem Cell*, *Nature Neuroscience*, and *Neuron*. Recent studies focus on cholinergic circuits in neurogenesis, hypothalamic modulation of cognitive function, and G9a inhibitors for Alzheimer’s. **Advising & Grants**: Mentors postdocs, graduate students, and undergraduates. Active in training programs like BBSP and MSTP. Her lab collaborates on projects involving neural stem cell regulation and circuit-based therapies. **Lab & Affiliations**: Song Lab (UNC Neuroscience Center) develops innovative tools like transdermal drug delivery systems and employs cutting-edge imaging techniques. Collaborates with institutions globally on neurodegenerative disease research.

Anand Krishnanمشاهده پروفایل

استادیار

• Nerve-tumor interface
• Nerve regeneration
• Cancer biology
• +۵ مورد دیگر

Dr. Anand Krishnan serves as Assistant Professor in the Department of Anatomy, Physiology and Pharmacology at the University of Saskatchewan's College of Medicine, where he leads research on nerve-tumor interfaces and neural macrophage biology. His work bridges neuroscience and oncology to identify therapeutic targets for cancer and neurodegenerative disorders. Education: Postdoctoral Fellow, Division of Neurology, University of Alberta, Canada Postdoctoral Fellow, Clinical Neurosciences, University of Calgary, Canada PhD in Biotechnology (Cancer Biology), Rajiv Gandhi Centre for Biotechnology, India Master of Pharmacy (Pharmacology), Manipal University, India Pharma R&D Experience: Orchid Chemicals and Pharmaceuticals Limited; Alembic Pharmaceuticals Limited Dr. Krishnan's research program investigates two core areas: molecular mapping of tumor-nerve interfaces to uncover novel therapeutic targets, and defining the roles of self-renewing resident macrophages in nervous system homeostasis and disease. His lab employs proteomics, murine models, and in vitro neuronal cultures to explore how tumors and nerves mutually support growth through neural invasion and autonomic signaling. Analysis of his 2020-2024 publications reveals consistent focus on neuro-oncology mechanisms, particularly peripheral nerve regeneration pathways (Myc interactome, growth-primed DRG), tumor-nerve crosstalk (sympathetic signaling in prostate cancer), and neurodegenerative targets (MANF). Key methodologies include comparative proteomics, molecular mapping, and drug repurposing screens. Research Funding: Natural Sciences and Engineering Research Council (NSERC) Cancer Research Society (CRS) CIHR Institute of Cancer Research Breast Cancer Society of Canada (BCSC) Prostate Cancer Fight Foundation (PCFF) & Ride for Dad Saskatchewan Health Research Foundation (SHRF) College of Medicine Research Award (CoMRAD) CoMBRIDGE Fund Start-up Research Fund Based at Saskatoon City Hospital within the Cameco MS Neuroscience Research Centre, the Krishnan Lab trains students supported by NSERC USRA, Dean's project fellowships, OVDR Biomedical research fellowships, and Mitacs awards. The lab's strategic location adjacent to the Meewasin Valley provides collaborative opportunities for translational neuroscience research focused on nerve regeneration and cancer therapeutics.

• Neurochemistry
• Alzheimer's Disease
• Biomarker Research
• +۳ مورد دیگر

Javier Saez Valero is a Professor in the Department of Biochemistry and Molecular Biology at Miguel Hernandez University of Elche, where he also serves as Deputy Vice Rector for Research - Management of Research and Transfer. His academic roles include teaching Biochemistry I in the Bachelor's in Medicine program and courses in the Master's in Neuroscience and Master's in Translational Neuropsychopharmacology, while coordinating the Doctorate in Neuroscience program. His research focuses on neurochemical mechanisms in neurodegenerative disorders, particularly Alzheimer's disease biomarker discovery in cerebrospinal fluid and blood. Key areas include NMDA receptor dynamics, ACE2 fragments, apolipoprotein E interactions, and reelin signaling pathways. His work bridges molecular biochemistry with clinical neurology to develop diagnostic tools and understand disease pathogenesis. Analysis of his 15 most recent publications (2023-2025) reveals a dominant focus on Alzheimer's disease biomarkers, especially CSF protein alterations (nicastrin, ADAM10, ACE2). Significant themes include synaptic vs extrasynaptic receptor distributions, COVID-19 neurological impacts, and nanocarrier drug delivery limitations. His work consistently targets translational applications for early diagnosis and therapeutic development. No scientific awards were documented in the provided information. Professor Saez Valero provides academic guidance through tutorials and course coordination across undergraduate, master's, and doctoral programs. As Doctorate in Neuroscience coordinator, he oversees research training while managing institutional research transfer activities through the Vice Rectorate. His teaching spans biochemistry, neuropathology, and molecular neuroscience with laboratory components. He operates from Laboratory 241 at the Institute of Neurosciences (Campus de San Juan), a joint research center with CSIC. His work integrates with the university's Vice Rectorate for Research and Transfer, facilitating technology transfer and collaborative neuroscience research within the university's research infrastructure.

Anders Nykjærمشاهده پروفایل

استاد

• Neuroscience
• Neurodegenerative Diseases
• Molecular Biology
• +۳ مورد دیگر

Anders Nykjær is a Professor at the Department of Biomedicine , Aarhus University , and Director of the DANDRITE - Nykjær Group . His research focuses on the role of VPS10p-domain receptors, particularly sortilin and SorCS2 , in neuronal viability, neurotrophic signaling, and neurodegenerative diseases. University: Aarhus University Department: Department of Biomedicine Lab: DANDRITE - Nykjær Group Nykjær's work spans neurodegenerative diseases (Alzheimer's, Huntington's), neurotrophic factors (BDNF, NGF), and receptor biology . His studies investigate how receptors like sortilin modulate amyloid-beta catabolism, dopaminergic neuron development, and neurovascular coupling. Recent articles highlight SorCS2 in motor neuron development and progranulin interactions. Article trends include neurovascular signaling (SorCS2 in astrocytic function), neurotrophic receptor dynamics (TrkB/GluN2B/SorCS2 complexes), and cardiovascular-neurological cross-talk (sortilin in atherosclerosis and diabetic retinal degeneration). His methods involve in vivo models, proteomics, and receptor-ligand interaction studies. Scientific contributions emphasize receptor biology in Neurodegenerative disease mechanisms Lipoprotein and neurotrophin receptor trafficking Neurovascular and synaptic signaling pathways

Zahoor Shahمشاهده پروفایل

استاد

• Neuroprotection
• Stroke Research
• Cerebrovascular Diseases
• +۳ مورد دیگر

Zahoor Shah, Ph.D. , is a Professor and Vice Chair in the Department of Medicinal and Biological Chemistry at the College of Pharmacy and Pharmaceutical Sciences , The University of Toledo . He serves as Associate Dean for Graduate Education and Research and Program Director . Dr. Shah obtained his doctorate in Toxicology from Hamdard University (New Delhi, India) and completed postdoctoral training at the University of Louisville (2005) and Johns Hopkins University (2007). 2005: Postdoctoral Fellow, University of Louisville 2007: Postdoctoral Fellow, Johns Hopkins University 2009: Instructor, Johns Hopkins University Dr. Shah’s research focuses on identifying molecular targets and developing drugs for ischemic and hemorrhagic brain injuries . Key areas include: Neuroprotective agents targeting oxidative stress and inflammation Role of Nrf2/HO1 pathway in stroke recovery Mechanistic studies of cofilin signaling in neuroinflammation Preclinical models of stroke (t-MCAO, pMCAO, BCCAO) and zebrafish Alzheimer’s models Development of ROS-sensitive nitric oxide synthase inhibitors Patents in oxidative stress-related therapies His 15 most recent articles (2022–2024) emphasize: Therapeutic targeting of cofilin and neuroinflammation in stroke and neurodegenerative diseases Interplay between gut microbiota and cognitive decline Preclinical validation of anti-inflammatory agents (e.g., triazole-pyrimidine hybrids) Impact of metabolic factors (diabetes, hyperglycemia) on brain injury outcomes Dr. Shah has received major grants including NINDS R01 (2020–2025) and NIA R01 (2018–2023), and holds patents for neuroprotective compositions (US Patent 10,590,119; provisional applications D2018-11 and D2019-35). He has published over 83 peer-reviewed articles and mentored numerous graduate and undergraduate students.

• Pharmacology
• Cholesterol Metabolism
• Alzheimer's Disease
• +۵ مورد دیگر

Bianca Papotti is a fixed-term Researcher at the Department of Food and Pharmaceutical Sciences, University of Parma. Her academic career spans interdisciplinary research in Pharmacology Cholesterol Metabolism Neurodegenerative Diseases Cardiovascular Pathology Immunometabolism . She teaches courses including Experimental Pharmacology and Food Toxicology. Her research focuses on the role of PCSK9 and cholesterol efflux in Alzheimer's Disease Atherosclerosis Rheumatoid Arthritis Lipoprotein Biology Inflammatory Disease Drug Development . Key trends in her publications (3 in 2025, 12 in 2024) reveal strong emphasis on PCSK9 inhibition mechanisms, cholesterol-immune crosstalk in rheumatoid arthritis, and fasting interventions in lipid-related pathologies. Her work has explored PCSK9's neuroinflammatory effects ABCA1/ABCG1 transporter dynamics Macrophage cholesterol loading Natural compound screening HDL dysfunction in diabetes Covid-19 lipid interactions .

• Neurodegenerative Diseases
• Axonal Transport
• Motor Neurone Disease
• +۳ مورد دیگر

Dr Andrew Grierson is a Senior Lecturer in Neuroscience at the School of Medicine and Population Health, University of Sheffield, based at the Sheffield Institute for Translational Neuroscience (SITraN). His research focuses on molecular mechanisms of neurodegenerative diseases with translational applications. His educational background includes: PhD in Molecular Genetics from the University of Sheffield (1991-1994) BSc in Genetics from the University of Sheffield (1988-1991) Dr Grierson's work centers on axonal transport regulation in motor neurone disease (MND) and hereditary spastic paraplegia (HSP) , utilizing zebrafish and mouse models to investigate disease mechanisms and therapeutic interventions. Current projects include HDAC6 inhibition studies for CMT2A and HSP, C9ORF72 protein function analysis in ALS, and spastin gene replacement therapy development. His laboratory emphasizes preclinical translation with strong industry and charity partnerships. Analysis of his 15 most recent publications (2013-2022) reveals consistent focus on ALS/MND pathophysiology, with increasing emphasis on C9ORF72-related mechanisms , mitochondrial dysfunction , and therapeutic target validation . The work bridges basic molecular neuroscience and clinical applications, predominantly using in vivo models and translational biomarkers . Dr Grierson supervises multiple PhD students and collaborates with Pamela Shaw and Bob Johnston at Sheffield. His research group includes technicians Katie Adamson and Gary Shaw, operating within SITraN's specialized facilities for neurodegenerative disease research.

Shahzad S. Khanمشاهده پروفایل

استادیار

• Neurodegeneration
• Aging
• Signal Transduction
• +۳ مورد دیگر

Shahzad S. Khan is an Assistant Professor at the University of North Carolina at Chapel Hill School of Medicine , affiliated with the Departments of Neurology and Cell Biology and Physiology . His research focuses on the molecular basis of neurodegeneration , aging mechanisms, and signal transduction in neurological diseases. Education : PhD in Neuroscience (2018) from The University of Virginia; Postdoctoral Scholar (2018-2023) at Stanford University; B.Sc. in Chemical Sciences (2011) from Florida State University His work combines mouse models , neural cultures , human brain samples , and advanced techniques like single-cell transcriptomics and proteomics to study Alzheimer’s and Parkinson’s diseases. Recent publications highlight LRRK2 kinase activity in cilia dynamics, tau signaling in Alzheimer’s, and hedgehog pathway disruptions in neurodegeneration. Key awards include the Rising Star Award (UNC, 2022), Stanford PRISM Fellowship (2017), and NIH predoctoral support (2016-2017). He leads the Khan Lab at UNC Neuroscience Research Building, investigating therapeutic targets for age-related neurodegenerative diseases.

Guoqiang Yuمشاهده پروفایل

استاد

• Machine Learning
• Pattern Recognition
• Optimization
• +۹ مورد دیگر

Guoqiang Yu is a Professor in the Bradley Department of Electrical and Computer Engineering at Virginia Tech. He holds a joint appointment at the Virginia Tech Research Center - Arlington. His research focuses on integrating machine learning, signal processing, and statistical methods to develop computational tools for analyzing multiplatform biomedical data. Key areas include neuroinformatics, bioinformatics, and systems biology, with applications in understanding human diseases through genomic, proteomic, and imaging data integration. Education: Ph.D. in Electrical Engineering, Virginia Tech (2011) Postdoctoral Fellowship at Stanford University (2012) M.S. Tsinghua University (2004) B.S. Shandong University (2001) Research Interests: Machine learning methodologies for biomedical data analysis, pattern recognition in complex datasets, optimization algorithms for high-dimensional data, stochastic signal processing, and their applications in neurodegenerative diseases (e.g., ALS, Alzheimer's), glial cell biology, and precision medicine. His work emphasizes developing open-source tools like ABDS, CAM3.0, and SynQuant for data normalization, deconvolution, and quantitative imaging analysis. Awards & Service: NSF Career Award (2018) Dean's Award for Excellence in Research (2022) Member of NIH BRAIN Initiative Consortium (2021–present) Associate Editor for BMC Bioinformatics (2017–present) Labs & Teams: Leads the Yu Lab at Virginia Tech, collaborating with multidisciplinary teams in neuroscience, bioengineering, and computational biology. Active in NIH-funded consortia focused on brain data science and large-scale neuroimaging initiatives.

Dhaval Joshiمشاهده پروفایل

پژوهشگر

• Neuroscience
• Addiction Studies
• Neurobiology
• +۳ مورد دیگر

Dhaval Joshi is a Researcher in the Department of Psychology at the University of Cambridge, affiliated with the Belin laboratory. His research focuses on understanding the neurobiological mechanisms underlying drug addiction, particularly the role of interoceptive mechanisms and the insular cortex. He investigates how astrocytic dopamine transporter regulation contributes to compulsive drug-seeking behaviors and the development of addiction-related habits. His work integrates neurobiological approaches to study addiction, including the impact of dopamine signaling in astrocytes across brain regions like the striatum. He also explores translational models of addiction and relapse prevention mechanisms. His recent studies highlight the significance of astrocyte-neuron interactions in modulating drug-seeking behaviors and the neuroplastic changes associated with addiction progression. His research interests span addiction neuroscience, neuropharmacology, and the neural circuits governing compulsive behaviors. While no specific awards are listed, his contributions to understanding the astrocytic role in addiction are notable within the field.

• Neurogenetics
• Neurodegenerative Diseases
• Mouse Models in Human Disease Research
• +۴ مورد دیگر

Professor Elizabeth Fisher is a leading academic in Neurogenetics at the UCL Queen Square Centre for Neuromuscular Diseases , affiliated with the Faculty of Brain Sciences at University College London. She specializes in mouse models for human neurodegenerative diseases. Undergraduate: Physiological Sciences, University of Oxford (1978–1981) PhD: Mouse Molecular Genetics, St Mary’s Hospital Medical School (Imperial College) and MRC Mammalian Genetics Unit (Harwell) (1983) Her research focuses on Down’s syndrome and amyotrophic lateral sclerosis (ALS) , using mouse models to investigate the neurological basis of these conditions. She collaborates extensively, including with Victor Tybulewicz since 1991. Recent publications highlight her work in neurogenetics , mouse modeling , and neurodegenerative disease mechanisms , including studies on ALS, Down syndrome, and metabolic alterations in genetically modified mice. Scientific recognitions include: Fellow of the Academy of Medical Sciences (2007) Member of EMBO (2009) Fellow of the Royal Society of Biology (2010) Wellcome Trust Senior Investigator (with Victor Tybulewicz) Her work emphasizes interdisciplinary collaboration and translational approaches, leveraging mouse genetics to address fundamental questions in neurodegeneration.

• Neuroscience
• Electron Microscopy
• Synaptic Connectivity
• +۳ مورد دیگر

Angel Merchan Perez is a faculty member at the Universidad Politécnica de Madrid , affiliated with the College of Computer Science and the Computer Systems Architecture and Technology Department . He is a key member of the Center for Biomedical Technology (CTB) since 2011 and the Technologies for Health Sciences Research Group since 2018. His work bridges neuroscience and computational technologies, focusing on ultrastructural analysis of the brain. Doctoral Postdoc: Harvard Medical School (1992-1995) Current Projects: Cajal Blue Brain Project, Human Brain Project His research focuses on developing advanced 3D electron microscopy techniques (FIB-SEM) for synaptic reconstruction, enabling quantitative analysis of synapse distribution and density in rat, mouse, and human cerebral cortex . He also contributed to image-analysis software like Espina for automated synapse detection. Recent publications highlight his expertise in: 3D Synaptic Mapping in Hippocampal Neurons Neurodevelopmental Disorder Pathology (Schizophrenia, Autism) Thalamocortical Circuit Complexity Mitochondrial Distribution in Neuropil Software Tools for Electron Microscopy